Matthew Kutny MD
Director, Clinical Trials Office, Children’s of Alabama
Join to View Full Profile
1600 7th Ave SBirmingham, AL 35233
Phone+1 205-934-3795
Fax+1 205-975-8991
Dr. Kutny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2008 - 2011
Vanderbilt University Medical CenterResidency, Pediatrics, 2005 - 2008
Vanderbilt University School of MedicineClass of 2005
Certifications & Licensure
AL State Medical License 2011 - 2025
WA State Medical License 2008 - 2013
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Start of enrollment: 2017 Nov 29
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
- Join now to see all
Publications & Presentations
PubMed
- Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.Hiroto Inaba, David Teachey, Colleen Annesley, Sandeep Batra, Jill Beck
Journal of the National Comprehensive Cancer Network. 2025-02-01 - 1 citationsOutcomes of Referrals in Pediatric Patients With Peripheral Lymphadenopathy.Kathryn A Six, Inmaculada B Aban, Gabriel M Daniels, Julie Wolfson, Elizabeth A Beierle
Journal of Pediatric Hematology/oncology. 2024-08-01 - 3 citationsBosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang
Journal of Clinical Oncology. 2024-03-01
Press Mentions
- Chemotherapy-Free Regimen Benefits Children with Acute Promyelocytic LeukemiaFebruary 2nd, 2022
- A Gentler Standard for Acute Promyelocytic Leukemia in KidsNovember 11th, 2021
Arsenic Trioxide Consolidation Effective in Pediatric Acute Promyelocytic LeukemiaAugust 21st, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
